Matt Larew

Work Performance Price Targets & Ratings Chart

Analyst Matt Larew, currently employed at WILLIAM BLAIR,

Most recent stock forecast was given on DNA, Ginkgo Bioworks Holdings at 26-Dec-2024.

Wall Street Analyst Matt Larew

Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
DNA Ginkgo Bioworks Holdings INNV InnovAge Holding Corp SGFY Signify Health ZY Zymergen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$7

$-3.08 (-30.56%)

$8

4 months 3 days ago
(23-Aug-2024)

2/5 (40%)

$-1.15 (-14.11%)

31

Sell

$12

$1.92 (19.05%)

$44

5 months 17 days ago
(09-Jul-2024)

3/3 (100%)

$-0.34 (-2.76%)

95

Hold

$40

$29.92 (296.83%)

$200

7 months 11 days ago
(15-May-2024)

0/2 (0%)

$6.44 (19.19%)

Buy

9 months 25 days ago
(01-Mar-2024)

0/1 (0%)

$310 (182.35%)

Hold

$100

$89.92 (892.06%)

1 years 1 months 12 days ago
(14-Nov-2023)

1/2 (50%)

$42.4 (73.61%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?